Hasil Pencarian - Isabelle Durand Zaleski

Perbaiki Hasil
  1. 1
    Decrementally cost-effective health technologies in non-inferiority studies: A systematic review

    Decrementally cost-effective health technologies in non-inferiority studies: A systematic review oleh Meryl Darlington, Raffaele Scarica, Xyomara Chavez-Pacheco, Laeticia Blamplain Segar, Isabelle Durand-Zaleski, Isabelle Durand-Zaleski

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.

    Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases. oleh Benjamin Cadier, Isabelle Durand-Zaleski, Daniel Thomas, Karine Chevreul

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Prognostic models for short-term annual risk of severe complications and mortality in patients living with type 2 diabetes using a national medical claim database

    Prognostic models for short-term annual risk of severe complications and mortality in patients living with type 2 diabetes using a national medical claim database oleh Alexandre Vimont, Sophie Béliard, René Valéro, Henri Leleu, Isabelle Durand-Zaleski

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013.

    In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013. oleh Rana Maroun, Franck Maunoury, Laure Benjamin, Gaëlle Nachbaur, Isabelle Durand-Zaleski

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Deploying and assessing telemedicine in the Paris region: progress report

    Deploying and assessing telemedicine in the Paris region: progress report oleh Isabelle Durand-Zaleski, Kevin Zarca, Nathanael Charrier, Laurent Treluyer, Christine Calinaud

    Diterbitkan 2013-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Deploying and assessing telemedicine in the Paris region: progress report

    Deploying and assessing telemedicine in the Paris region: progress report oleh Isabelle Durand-Zaleski, Kevin Zarca, Nathanael Charrier, Laurent Treluyer, Christine Calinaud

    Diterbitkan 2013-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    How to perform a cost-effectiveness analysis with surrogate endpoint: renal denervation in patients with resistant hypertension (DENERHTN) trial as an example

    How to perform a cost-effectiveness analysis with surrogate endpoint: renal denervation in patients with resistant hypertension (DENERHTN) trial as an example oleh Julie Bulsei, Meryl Darlington, Isabelle Durand-Zaleski, Michel Azizi, The DENERHTN Study Group

    Diterbitkan 2018-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Impact of the switch from four to three intradermal rabies post-exposure prophylaxis sessions in patients bitten by dogs: A cost-consequence analysis from the patients' perspective

    Impact of the switch from four to three intradermal rabies post-exposure prophylaxis sessions in patients bitten by dogs: A cost-consequence analysis from the patients' perspective oleh Alicia Le Bras, Kevin Zarca, Yiksing Peng, Malen Chan, Isabelle Durand-Zaleski

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment

    Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment oleh François R. Girardin, Karen Cohen, Matthias Schwenkglenks, Matthias Schwenkglenks, Isabelle Durand-Zaleski

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires

    Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires oleh Maud Beillat, Isabelle Durand-Zaleski, France Pirenne, Stève Bénard, Louis Chillotti, Frédéric Galacteros

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Non-financial conflicts of interest in academic grant evaluation: a qualitative study of multiple stakeholders in France.

    Non-financial conflicts of interest in academic grant evaluation: a qualitative study of multiple stakeholders in France. oleh Hendy Abdoul, Christophe Perrey, Florence Tubach, Philippe Amiel, Isabelle Durand-Zaleski, Corinne Alberti

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Lung CAncer SCreening in French women using low-dose CT and Artificial intelligence for DEtection: the CASCADE study protocol

    Lung CAncer SCreening in French women using low-dose CT and Artificial intelligence for DEtection: the CASCADE study protocol oleh Isabelle Durand-Zaleski, Hendy Abdoul, Marie Wislez, Marie-Pierre Revel, Guillaume chassagnon, Emma Canniff

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Tele-expertise for diagnosis of skin lesions is cost-effective in a prison setting: A retrospective cohort study of 450 patients.

    Tele-expertise for diagnosis of skin lesions is cost-effective in a prison setting: A retrospective cohort study of 450 patients. oleh Kevin Zarca, Nathanael Charrier, Emmanuel Mahé, Fabien Guibal, Béatrice Carton, François Moreau, Isabelle Durand-Zaleski

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Peer review of grant applications: criteria used and qualitative study of reviewer practices.

    Peer review of grant applications: criteria used and qualitative study of reviewer practices. oleh Hendy Abdoul, Christophe Perrey, Philippe Amiel, Florence Tubach, Serge Gottot, Isabelle Durand-Zaleski, Corinne Alberti

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study

    Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study oleh Luc Jaulmes, Youri Yordanov, Alexandre Descamps, Isabelle Durand-Zaleski, Aurélien Dinh, Patrick Jourdain, Agnès Dechartres

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data

    Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data oleh Rana Maroun, Laura Mitrofan, Laure Benjamin, Gaelle Nachbaur, Franck Maunoury, Philippe Le Jeunne, Isabelle Durand-Zaleski

    Diterbitkan 2018-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    The cost of illness and burden of suicide and suicide attempts in France

    The cost of illness and burden of suicide and suicide attempts in France oleh Laeticia Blampain Segar, Charles Laidi, Ophélia Godin, Philippe Courtet, Guillaume Vaiva, Marion Leboyer, Isabelle Durand-Zaleski

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Parkinson’s disease with early motor complications: predicting EQ-5D- 3L utilities from PDQ-39 data in the EARLYSTIM trial

    Parkinson’s disease with early motor complications: predicting EQ-5D- 3L utilities from PDQ-39 data in the EARLYSTIM trial oleh Mehdi Zahra, Isabelle Durand-Zaleski, Michal Górecki, Silke Walleser Autiero, Gillian Barnett, W. M. Michael Schüpbach

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Cost and outcomes of the ultrasound screening program for birth defects over time: a population-based study in France

    Cost and outcomes of the ultrasound screening program for birth defects over time: a population-based study in France oleh Babak Khoshnood, Jean-Marie Jouannic, Clément Ferrier, Ferdinand Dhombres, Hanitra Randrianaivo, Isabelle Perthus, Isabelle Durand-Zaleski

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer

    Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer oleh Étienne Audureau, Isabelle Durand-Zaleski, Maxime Ronot, Pierre Nahon, Samia Baloul, Olivier Sutter, Pierre-André Natella

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: